gallium has been researched along with Infections, Pseudomonas in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Y; Qiao, Y; Wang, W; Yao, K; Ye, Y; Yu, Y; Zhou, M | 1 |
| Angarita-Zapata, V; Belmont-Díaz, J; Cazares, A; Coria-Jiménez, R; García-Contreras, R; Jasso-Chávez, R; López-Jacome, LE; Maeda, T; Sanchez-Torres, V; Tovar-García, A | 1 |
| Aitken, ML; Anderson, GD; Becker, L; Britigan, BE; Caldwell, E; Czyz, DM; Goss, CH; Hornick, DB; Kaneko, Y; Khuu, L; Lechtzin, N; McLean, K; Olakanmi, O; Ravishankar, S; Salipante, SJ; Shuman, HA; Siehnel, RJ; Singh, PK; Teresi, M; Wilhelm, E; Zhou, G | 1 |
| Coria-Jiménez, R; García-Contreras, R; Jasso-Chávez, R; Lira-Silva, E; Maeda, T; Pérez-Eretza, B; Rangel-Vega, A; Wood, TK | 1 |
| Coria-Jimenez, R; García-Contreras, R; García-Lara, B; Lee, J; Pérez-Eretza, B; Ramasamy, M; Roldán-Sánchez, JA; Saucedo-Mora, MÁ; Tapia, M; Varela-Guerrero, V | 1 |
| Banin, E; Berenshtein, E; Brady, KM; Butterfield, PW; Chevion, M; Greenberg, EP; Lozinski, A; Moshe, M | 1 |
| Alipour, M; Azghani, AO; Halwani, M; Omri, A; Suntres, ZE; Yebio, B | 1 |
| Balldin, F; DeLeon, K; Griswold, J; Hamood, A; Rumbaugh, KP; Sreedharan, S; Watters, C | 1 |
| Antoniadou, A; Batsakis, C; Christakopoulos, J; Dounis, E; Giamarellou, H; Grecka, V; Kanellakopoulou, K; Koratzanis, G; Malamitsi, J; Panoutsopoulos, G; Proukakis, C | 1 |
| Harvey, WC; Kapp, DT; Podoloff, DA | 1 |
2 trial(s) available for gallium and Infections, Pseudomonas
| Article | Year |
|---|---|
Gallium disrupts bacterial iron metabolism and has therapeutic effects in mice and humans with lung infections.
Topics: Adolescent; Adult; Animals; Anti-Bacterial Agents; Bacterial Proteins; Cystic Fibrosis; DNA Transposable Elements; Drug Resistance, Bacterial; Drug Synergism; Gallium; Genes, Bacterial; Humans; Iron; Lung; Macrophages; Mice, Inbred C57BL; Microbial Viability; Middle Aged; Mutagenesis; Mutation; Oxidants; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Sputum; Young Adult | 2018 |
Infecton: a 99mTc-ciprofloxacin radiopharmaceutical for the detection of bone infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Ciprofloxacin; Citrates; Diphosphonates; Female; Gallium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Organotechnetium Compounds; Osteomyelitis; Predictive Value of Tests; Pseudomonas Infections; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Staphylococcal Infections; Technetium; Tomography, X-Ray Computed | 2003 |
8 other study(ies) available for gallium and Infections, Pseudomonas
| Article | Year |
|---|---|
Gallium-Based Nanoplatform for Combating Multidrug-Resistant
Topics: Animals; Anti-Bacterial Agents; Bacteria; Cataract; Endophthalmitis; Gallium; Inflammation; Iron; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits | 2022 |
Characterization of gallium resistance induced in a Pseudomonas aeruginosa cystic fibrosis isolate.
Topics: Anti-Bacterial Agents; Cystic Fibrosis; Drug Repositioning; Drug Resistance, Bacterial; Gallium; Humans; Oligopeptides; Pseudomonas aeruginosa; Pseudomonas Infections; Pyocyanine | 2020 |
Gallium induces the production of virulence factors in Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Cystic Fibrosis; Gallium; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Virulence Factors | 2014 |
Inhibition of quorum-sensing-dependent virulence factors and biofilm formation of clinical and environmental Pseudomonas aeruginosa strains by ZnO nanoparticles.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cystic Fibrosis; Drug Resistance, Bacterial; Furans; Gallium; Humans; Metal Nanoparticles; Pancreatic Elastase; Pseudomonas aeruginosa; Pseudomonas Infections; Pyocyanine; Quorum Sensing; Virulence; Virulence Factors; Zinc Oxide | 2015 |
The potential of desferrioxamine-gallium as an anti-Pseudomonas therapeutic agent.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Deferoxamine; Drug Therapy, Combination; Eye Infections, Bacterial; Gallium; Gentamicins; Iron; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Treatment Outcome | 2008 |
Co-encapsulation of gallium with gentamicin in liposomes enhances antimicrobial activity of gentamicin against Pseudomonas aeruginosa.
Topics: Acyl-Butyrolactones; Agrobacterium tumefaciens; Anti-Bacterial Agents; Biofilms; Cell Line; Cell Survival; Cystic Fibrosis; Drug Synergism; Epithelial Cells; Gallium; Gentamicins; Humans; Liposomes; Microbial Sensitivity Tests; Microbial Viability; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum; Trypan Blue | 2008 |
Gallium maltolate treatment eradicates Pseudomonas aeruginosa infection in thermally injured mice.
Topics: Acinetobacter baumannii; Animals; Burns; Female; Gallium; Mice; Organometallic Compounds; Pseudomonas Infections; Pyrones; Staphylococcus aureus | 2009 |
67Gallium in 68 consecutive infection searches.
Topics: Abscess; Adult; Arthritis; Bronchiectasis; Cholangitis; Coccidioidomycosis; False Negative Reactions; False Positive Reactions; Gallium; Haemophilus Infections; Humans; Infections; Lung Abscess; Meningococcal Infections; Osteomyelitis; Pneumonia; Pressure Ulcer; Pseudomonas Infections; Radioisotopes; Radionuclide Imaging; Staphylococcal Infections; Subphrenic Abscess; Suppuration; Wound Infection | 1975 |